Tag Archives: Healthcare

 HomeBizzell US  Blog  Healthcare
Categories Blog Tags Healthcare, Mental Health, Substance Use Disorder (SUD)

Bridging Gaps in Public Health: Bizzell’s Trusted Partnership for Vital Health Programs

Bridging Gaps in Public Health: Bizzell’s Trusted Partnership for Vital Health Programs

By Editorial Staff

For more than a decade, Bizzell US (Bizzell) has contributed to developing a wide range of services across the public health sector, including a broad spectrum of healthcare services, ranging from primary care to specialized treatments, focusing on enhancing individual health and well-being. Our clinical teams are committed to providing high-quality patient care, ensuring comprehensive support across various medical needs. Bizzell is deeply invested in advancing public health through targeted initiatives aimed at disease prevention, health promotion, and community empowerment. By partnering with local stakeholders and organizations, we address health disparities and strive to improve health outcomes, fostering healthier and more resilient communities. Our most recent campaigns have surrounded the current COVID-19 pandemic, treating substance use disorder, workforce training and development, women and youth empowerment, equity, and mental health.

Since the onset of the COVID-19 pandemic, Bizzell has been actively engaged in the fight against the virus, working tirelessly to implement comprehensive response strategies. From facilitating vaccination campaigns to providing logistical support for testing and contact tracing initiatives, Bizzell has played a vital role in mitigating the spread of the virus and protecting public health. Through collaboration with government agencies, healthcare organizations, and communities, Bizzell has demonstrated its unwavering commitment to combatting COVID-19 and safeguarding the well-being of individuals and families.

Recognizing the devastating impact of substance abuse on individuals and communities, Bizzell has contributed to the development of evidence-based prevention and treatment programs tailored to address the unique needs of diverse populations. By partnering with stakeholders at all levels, Bizzell has amplified efforts aimed at reducing substance abuse, promoting recovery, and supporting individuals and families affected by addiction. Through education, outreach, and community engagement initiatives, Bizzell has raised awareness about substance abuse issues, reduced stigma, and connected individuals with vital support services.

Bizzell is dedicated to promoting mental health and well-being by working on programs to improve access to quality mental health services and resources. Through workforce training programs, public awareness campaigns, and community-based interventions, Bizzell has worked to destigmatize mental illness and increase access to mental health care. By addressing the social determinants of mental health and promoting resilience and empowerment, Bizzell strives to improve the overall well-being of individuals and communities.

Bizzell recognizes the importance of addressing health disparities and ensuring equitable access to healthcare services for all. By collaborating with underserved communities and implementing culturally responsive interventions, Bizzell seeks to eliminate barriers to care and improve health outcomes among vulnerable populations. Bizzell is committed to building healthier and more equitable communities through initiatives promoting health equity and social justice.

Bizzell’s impact extends beyond national borders, with initiatives to address global health challenges and promote international collaboration. Through capacity-building efforts, disease surveillance programs, and humanitarian assistance projects, Bizzell leverages its expertise and resources to support global health initiatives and strengthen health systems worldwide. By partnering with international organizations and local stakeholders, Bizzell addresses the root causes of health disparities and promotes sustainable solutions for improved health outcomes.

Additionally, Bizzell delivers comprehensive behavioral health services tailored to support individuals and families facing mental health challenges, including counseling, therapy, and substance abuse treatment. Through advanced data analytics and population health management strategies, we assist healthcare organizations in optimizing care delivery and enhancing health outcomes for entire populations, addressing healthcare needs at the community level. Our commitment extends to rigorously examining preventive health programs, leveraging health technology solutions, fostering community health partnerships, engaging in health education and outreach initiatives, evaluating telehealth solutions, reviewing chronic disease management approaches, and participating in global health initiatives to promote health equity worldwide.

Bizzell’s decade-long commitment to public health excellence underscores its dedication to making a meaningful difference in the lives of individuals and communities. Through its work in addressing COVID-19, substance abuse, mental health, and health disparities, Bizzell has demonstrated its unwavering commitment to promoting health and well-being for all. As we look to the future, Bizzell remains steadfast in its mission to drive positive change and create healthier, more resilient communities at home and abroad.

Categories Blog Tags Centers for Disease Control and Prevention (CDC), Data Analytics, Healthcare

Leveraging Data Analytics to Reduce Patient Readmissions: Bizzell’s Impact on Healthcare Quality

Leveraging Data Analytics to Reduce Patient Readmissions: Bizzell’s Impact on Healthcare Quality

By Editorial Staff

Hospitals face many unseen challenges in today’s ever-changing medical landscape. Service utilization, rising care costs, patient readmissions, optimal staffing, and insurance navigation are but a few issues that may arise in healthcare settings. Reducing patient readmissions is a critical priority in healthcare, as it improves patient outcomes and helps alleviate the strain on healthcare resources. In this realm, Bizzell US (Bizzell) stands out as an industry leader, harnessing the power of data analytics to drive transformative change and enhance patient care. High rates of patient readmissions present significant challenges and costs to healthcare systems. According to the Centers for Disease Control (CDC), over $52.4 billion (about $160 per person in the US) is spent annually to care for patients readmitted to the hospital within 30 days (about four weeks) for a previously treated condition[1]Is the Hospital Value-Based Purchasing Program Associated with Reduced Hospital Readmissions? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113654/. Frequent readmissions strain already stretched healthcare resources, especially amid the rise of COVID-19.

Various analytics techniques shape healthcare strategies. These strategies include predictive, prescriptive, descriptive, and discovery analytics. Predictive analytics aid in anticipating patient outcomes and optimizing prevention efforts, while prescriptive analytics focuses on treatment optimization. Descriptive analytics help us understand healthcare trends over time, including quality of care. It is often used to create reports about changes in historical data over time.

An example of this could be to look at how many face masks are ordered during a pandemic and the types requested during each pandemic. Prescriptive analytics occur when health problems are complex and fuse medical knowledge with data. Most evidence-based medical treatments are supported by prescriptive analytics.

Leveraging a complete spectrum of analytic tools enables us at Bizzell to redefine patient care and enhance the healthcare experience. Predictive analytics also operate on past performance, summarizing historical data to visualize new trends. Predicting risks in drug dosages, clinical trials, epidemic spreads, etc., these analytics find hidden patterns and illuminate them for healthcare professionals. Funding and allocation of funds are moved around utilizing these analytics. Planning healthcare resources, such as how many gauzes or vaccines to order, are confirmed through analytics. Discovery analytics uses knowledge to discover new medical trends, including treatments or instruments[2]The use of Big Data Analytics in healthcare https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733917/.

At Bizzell, our team of analytics experts is at the forefront of leveraging big data to support the reduction of patient readmissions. From analyzing patient records and drug costs to transforming clinical practice, our commitment to improving healthcare quality and administration shines through in every project we undertake.

Data analytics empower healthcare agencies to make informed decisions and revolutionize their approaches to healthcare delivery. Bizzell, a leader in the field, utilizes advanced analytic methodologies to extract actionable insights from vast datasets. For instance, Bizzell’s support of heart disease and stroke prevention involves sophisticated GIS analyses and statistical modeling to inform strategic priorities and program effectiveness.

Bizzell’s innovative solutions have yielded tangible results in reducing patient readmissions across various healthcare settings. For instance, by implementing predictive analytics models, we successfully identified at-risk patients and implemented targeted interventions to prevent readmissions. These interventions have significantly improved patient outcomes and healthcare efficiency, demonstrating the efficacy of Bizzell’s approaches. We assist our clients by applying advanced machine learning or predictive modeling techniques that uncover hidden patterns that contribute to our hospital partners not functioning optimally. From crisis planning and women’s health to combatting higher readmission rates, the need for data collection is high, but the value lies in the ability to sift through it all to find a true story.

The benefits of utilizing analytics in hospitals cannot be emphasized enough. Beyond cost savings, we aim to encompass improved patient outcomes and enhanced healthcare quality nationwide. Our partnership with the Centers for Medicare & Medicaid Services (CMS) prospective payment system (PPS) for inpatient psychiatric facilities (IPFs) shows examples of our commitment to this work. Our focus was to re-adjust the standardized federal per diem payment rates paid to the 1,535 participating hospitals nationwide to account for cost changes (like wages) and resource utilization. These rate adjustments consider the beneficiary’s age, selected chronic conditions, and facility-level adjustments on ruralness, teaching status, and qualifying emergency department visits. In 2019, IPFs collectively served over 200,000 Medicare beneficiaries. For this project, ensuring we had the correct data and comparing the data over time was crucial for success.

There is immense potential for further advancements in using analytics to address patient readmissions and other factors contributing to hospital challenges, such as high supply costs, underutilized services, and streamlining healthcare processes. Bizzell remains at the forefront of this innovation, continuously striving to refine its methodologies and expand its impact. By contributing to ongoing efforts to improve healthcare quality and efficiency, Bizzell is driving positive change and shaping the future of healthcare delivery.

References

[1] Is the Hospital Value-Based Purchasing Program Associated with Reduced Hospital Readmissions? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113654/#:~:text=A%20significant%20portion%20of%20the, be%20attributed%20to%20hospital%20readmission.&text=In%20addition%2C%20over%20%2452.4%20billion, for%20a%20previously%20treated%20condition
[2] The use of Big Data Analytics in healthcare https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733917/#:~:text=descriptive%20analytics%20in%20 healthcare%20is,making%20informed%20decisions%20%5B33%5D

group of people in a circle looking down at the camera
Categories News Tags CEO News, Health, Healthcare, National Cancer Institute (NCI), Tobacco Research

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

 

July 27, 2022 (New Carrollton, MD) — The Bizzell Group is proud to provide direct support to the National Cancer Institute, part of the National Institutes of Health, in the development of Tobacco Control Monograph 23—Treating Smoking in Cancer Patients: An Essential Component of Cancer Care. Released on June 29th, the monograph expands upon prior research from the 2014 and 2020 Surgeon General’s reports to inform clinicians and their patients with cancer about the science and practice of quitting smoking. The monograph also builds on recent findings from the National Cancer Institute’s (NCI) Moonshot℠ Cancer Center Cessation Initiative (C3I) program. “The monograph provides evidence that clinicians, public health practitioners, researchers, and patients with cancer can use to help influence real-world change in the treatment of patients with cancer who smoke. I am grateful for the opportunity to collaborate with NCI and subject matter experts to produce a rigorous volume on such an important topic,” said Jenny Twesten, Managing Director of Health Communications & Research at Bizzell, who oversaw the editorial and publication support for the monograph.

Smoking cessation treatment is rarely addressed in cancer care settings, yet the research summarized in the monograph demonstrates that quitting smoking is among the most effective treatment options for improving the likelihood of survival, quality of life, and overall health of people with cancer who smoke. The monograph also provides clinicians with evidence-based strategies and treatment options they can implement to better address smoking with cancer patients.
“Monograph 23 leverages prior academic research to demonstrate that addressing smoking cessation within the cancer treatment protocol yields tremendous benefits. I am greatly appreciative of the rigorous development process led by the Federal staff, Scientific Editorial Committee, peer-review experts, and the Bizzell team” said Anton C. Bizzell, M.D., President and CEO of Bizzell.

To read the full monograph, please visit: https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-23

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

Categories News Tags Awards, Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), Communications & Outreach, COVID-19, Food and Drug Administration (FDA), Health, Healthcare, Project Awards, Special Populations

Bizzell Wins Three MUSE Creative Awards for Public Health Projects

Bizzell Wins Three MUSE Creative Awards for Public Health Projects

September 30, 2021 (New Carrollton, MD) – The Bizzell Group (Bizzell), one of the fastest growing companies in America according to Inc. Magazine and Washington Business Journal, has won three MUSE Creative Awards, including one Gold and two Silver awards. Bizzell was recognized for integrated marketing content, websites, and publications designed to support the U.S. Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) to tackle critical public health issues including the COVID-19 pandemic.

This year, Bizzell received the Gold MUSE Creative Award for the BeSafeRx Relaunch, a national campaign sponsored by the FDA to educate consumers and healthcare providers about the potential dangers of buying prescription medicine online.

Bizzell received a Silver MUSE Creative Award for the CMS-CDC Fundamentals of COVID-19 Prevention for Nursing Home Management website—an on-demand nursing home training series designed to help address the infection prevention challenges impacting long-term care facilities due to the COVID-19 pandemic. Bizzell also received a Silver award for the CMS Toolkit on State Action to Mitigate COVID-19 Prevalence—a publication of curated content designed to facilitate and share best practices to manage the spread of COVID-19 in nursing homes.

Bizzell’s clients drive real world change and Bizzell staff accelerate it. According to Anton C. Bizzell, M.D., Founder and CEO of Bizzell, “during this COVID-19 pandemic, our clients need creativity and innovation. The Bizzell team delivered and disseminated solutions to help the public access critical information on prescriptions drugs and supported health care providers with enhanced quality improvement tools and resources during unprecedented times.”

The MUSE Awards is a series of international competitions hosted by the International Awards Associate (IAA), catering to professionals from various industries in hopes of promoting excellence in their respective fields. “There is a saying that ‘there is nothing new under the sun’,” said Kenjo Ong, CEO of IAA. “It couldn’t be any further from the truth – there is always something fresh and exciting from the competitors every year.”

IAA ensures impartiality and strict assessment criteria by setting up a jury made up of industry professionals who exhibit high standards of excellence. In turn, the jury would select a new wave of excellent individuals or organizations, who would likely set new benchmarks in their fields.

About The MUSE Creative Awards

The MUSE Creative Awards is part of the MUSE Awards Program, which was created by the IAA in 2015. IAA’s inception was based on a mission to honor, promote and encourage creativity by providing a new standard of excellence for evaluation media design production and distribution. IAA’s mission has largely shaped MCA’s goal.

At its core, MUSE Creative Awards international competition inspires creative professionals to strive for to greater heights. With their concepts, ideas or designs, these creatives light a fire in each other, thus becoming a muse.

Website: MUSE Creative Awards / MUSE Design Awards

Facebook: MUSE Awards

Twitter: MUSE Awards

Instagram: MUSE Awards 

About Bizzell

Established in 2010, The Bizzell Group (Bizzell) is a U.S. Small Business Administration (SBA) 8(a) certified strategy, consulting, and technology firm that designs innovative solutions to help build healthy, secure, and sustainable communities around the world. Bizzell’s expert staff and consultants support health, scientific, education, environmental, research, and information technology projects that advance national priorities. Learn more about how Bizzell develops data-driven, research-informed, innovative solutions at: www.BizzellUS.com.

1 2 3
Bizzell US